发明名称 CRYSTALLINE EFAVIRENZ
摘要 The potent reverse transcriptase inhibitor Efavirenz is produced in crystalline form. Crystalline Efavirenz exists in several physical forms which are designated Forms 1, 2, 3, 4 and 5 and are characterized by x-ray powder diffraction and differential scanning calorimetry. Pharmaceutical compositions and methods are useful for the treatment of the human immunodeficiency virus (HIV).
申请公布号 PL198504(B1) 申请公布日期 2008.06.30
申请号 PL19990345221 申请日期 1999.06.10
申请人 BRISTOL-MYERS SQUIBB PHARMA COMPANY 发明人 RADESCA LILIAN A.;MAURIN MICHAEL B.;RABEL SHELLEY R.;MOORE JAMES R.
分类号 C07D265/18;A61K31/535;A61K31/536;A61P31/18;A61P37/04 主分类号 C07D265/18
代理机构 代理人
主权项
地址